Procore chair exercises options, sells 56K shares
Procore Technologies chairman Craig F. Courtemanche Jr. exercised options for 56,122 shares of common stock at $2.42 per share and sold the same 56,122 shares in open-market transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Procore Technologies chairman Craig F. Courtemanche Jr. exercised options for 56,122 shares of common stock at $2.42 per share and sold the same 56,122 shares in open-market transactions. The sales were executed at weighted average prices between $47.08 and $49.745 under a Rule 10b5-1 trading plan dated December 9, 2025. Following these transactions, he holds 927,580 shares directly and additional indirect holdings through several family trusts and his spouse.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 56,122 | $2.42 | $136K |
| Exercise | Common Stock | 56,122 | $2.42 | $136K |
| Sale | Common Stock | 48,465 | $47.45 | $2.30M |
| Sale | Common Stock | 4,922 | $48.43 | $238K |
| Sale | Common Stock | 2,735 | $49.54 | $135K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (8)
- F1. These shares sold pursuant to a 10b5-1 plan dated December 9, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $47.08 to $47.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $48.08 to $49.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $49.12 to $49.745, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. These shares are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012.
- F6. These shares are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021.
- F7. These shares are held by The Courtemanche 2016 Irrevocable Trust.
- F8. The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date.
Key Figures
Key Terms
Rule 10b5-1 plan financial
Stock Option (Right to Buy financial
weighted average price financial
indirect financial
irrevocable trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Procore (PCOR) chairman Craig Courtemanche do in this Form 4?
Was the Procore (PCOR) insider sale under a Rule 10b5-1 plan?
What options did the Procore (PCOR) chairman exercise in this filing?
How are the Procore (PCOR) insider’s indirect holdings structured?
AI-generated analysis. How Rhea-AI works. Not financial advice.